Big Data Genetics Genome Genomics 
Drug Discovery World
AUGUST 3, 2023
This is the latest episode of the free DDW narrated podcast, “What lies in the future for genomics and big data?”, They are called “ What’s the next step in big data and AI? ” and “ Why a recent advancement is a giant leap for human genomics ”.
BioTech 365
APRIL 16, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Scientists are on a path to sequencing 1 million human genomes and use big data to unlock genetic secrets.The first draft of the human genome was published … Continue reading →
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ACRP blog
JUNE 7, 2023
If you hadn’t already noticed, the clinical research enterprise has well and truly entered the era of “big data,” artificial intelligence (AI), and machine learning. Edited by Gary Cramer The post Recognizing the Real People Behind the Big Data and Artificial Intelligence in Clinical Research appeared first on ACRP.
Drug Discovery World
JUNE 5, 2024
million to fund a new two-year collaborative partnership with King’s College London (KCL) to validate a portfolio of human genetic driven therapeutic targets for motor neuron disease (MND). Historical pipeline data suggests that drug targets with human genetic disease association are twice as likely to lead to approved drugs.
Drug Discovery World
JULY 11, 2023
Drug discovery and development timelines can span 10-15 years or more from initial discovery to market approval and typically require the analysis of massive amounts of data. One system that has been especially useful in generating relevant and accurate biological data is the patient- derived xenograft (PDX) model for cancer studies.
pharmaphorum
SEPTEMBER 16, 2022
Essentially, the collaboration brought together both “the right expertise and the right technology”, opening up myriad possibilities for targeting GPCRs within the human genome. Verily’s Immune Profiler can, Kim asserted, “generate more than 8 million immune measures across 24 immune cell subsets”. What, then, is the solution?
Drug Discovery World
JULY 17, 2024
A global collaboration led by scientists at the University of Oxford has discovered that genetic variants in a specific gene cause a rare neurodevelopmental disorder (NDD). This discovery was initially made using data from the 100,000 Genomes Project, a study led by Genomics England and NHS England.
Expert insights. Personalized for you.
52 
Let's personalize your content